New insights into the pathogenesis of ANCA-positive vasculitides;Vascularites ANCA-positives : données physiopathologiques récentes

Presse Medicale

Volumn 36, Issue 5 II, 2007, Pages 854-859

  Guilpain, Philippe ^a,b   Guillevin, Loïc ^a   Mouthon, Luc ^a,b  

^a Hôpital Cochin ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; IMMUNOSUPPRESSIVE AGENT; MYELOBLASTIN; MYELOPEROXIDASE; PROPYLTHIOURACIL;

ANCA ASSOCIATED VASCULITIS; ANTIGEN EXPRESSION; CYTOPLASM; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; SHORT SURVEY; WEGENER GRANULOMATOSIS;

EID: 34247396635     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.01.031     Document Type: Short Survey

References (34)

1. van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1 (1985) 425-429
2. Bligny D., Mahr A., Toumelin P.L., Mouthon L., and Guillevin L. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum 51 (2004) 83-91
3. Guillevin L., Durand-Gasselin B., Cevallos R., Gayraud M., Lhote F., Callard P., et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42 (1999) 421-430
4. Sable-Fourtassou R., Cohen P., Mahr A., Pagnoux C., Mouthon L., Jayne D., et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143 (2005) 632-638
5. Falk R.J., Terrell R.S., Charles L.A., and Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87 (1990) 4115-4119
6. Guilpain P., Chanseaud Y., Tamby M.C., Mahr A., Servettaz A., Guillevin L., et al. Pathogénie des vascularites systémiques primitives (I) : vascularites ANCA-positives. Presse Med 34 (2005) 1013-1022
7. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002) 955-963
8. Xiao H., Heeringa P., Liu Z., Huugen D., Hu P., Maeda N., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167 (2005) 39-45
9. Huugen D., Xiao H., van Esch A., Falk R.J., Peutz-Kootstra C.J., Buurman W.A., et al. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167 (2005) 47-58
10. Bansal P.J., and Tobin M.C. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93 (2004) 398-401
11. Rose N.R., and Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14 (1993) 426-430
12. Pfister H., Ollert M., Frohlich L.F., Quintanilla-Martinez L., Colby T.V., Specks U., et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104 (2004) 1411-1418
13. Pendergraft III W.F., Preston G.A., Shah R.R., Tropsha A., Carter Jr. C.W., Jennette J.C., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10 (2004) 72-79
14. Csernok E., Ai M., Gross W.L., Wicklein D., Petersen A., Lindner B., et al. Wegener's autoantigen induces maturation of dendritic cells and licences them for TH1 priming via the protease-activated receptor-2 pathway. Blood 107 (2006) 4440-4448
15. Voswinkel J., Mueller A., Kraemer J.A., Lamprecht P., Herlyn K., Holl-Ulrich K., et al. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 65 (2006) 859-864
16. Krumbholz M., Specks U., Wick M., Kalled S.L., Jenne D., and Meinl E. BAFF is elevated in serum of patients with Wegener's granulomatosis. J Autoimmun 25 (2005) 298-302
17. Jagiello P., Aries P., Arning L., Wagenleiter S.E., Csernok E., Hellmich B., et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52 (2005) 4039-4043
18. Witko-Sarsat V., Lesavre P., Lopez S., Bessou G., Hieblot C., Prum B., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10 (1999) 1224-1233
19. Rarok A.A., Stegeman C.A., Limburg P.C., and Kallenberg C.G. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 13 (2002) 2232-2238
20. Csernok E., Ernst M., Schmitt W., Bainton D.F., and Gross W.L. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95 (1994) 244-250
21. Csernok E., Szymkowiak C.H., Mistry N., Daha M.R., Gross W.L., and Kekow J. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol 105 (1996) 104-111
22. Schreiber A., Otto B., Ju X., Zenke M., Goebel U., Luft F.C., et al. Membrane proteinase 3 expression in patients with Wegener's granulomatosis and in human hematopoietic stem cell-derived neutrophils. J Am Soc Nephrol 16 (2005) 2216-2224
23. Schreiber A., Luft F.C., and Kettritz R. Membrane proteinase 3 expression and ANCA-induced neutrophil activation. Kidney Int 65 (2004) 2172-2183
24. Radford D.J., Luu N.T., Hewins P., Nash G.B., and Savage C.O. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 44 (2001) 2851-2861
25. Little M.A., Smyth C.L., Yadav R., Ambrose L., Cook H.T., Nourshargh S., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106 (2005) 2050-2058
26. Woywodt A., Streiber F., de Groot K., Regelsberger H., Haller H., and Haubitz M. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 361 (2003) 206-210
27. Holmen C., Elsheikh E., Stenvinkel P., Qureshi A.R., Pettersson E., Jalkanen S., et al. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 16 (2005) 3110-3120
28. Chanseaud Y., Pena-Lefebvre P.G., Guilpain P., Mahr A., Tamby M.C., Uzan M., et al. IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 109 (2003) 165-178
29. Peen E., Hahn P., Lauwers G., Williams Jr. R.C., Gleich G., and Kephart G.M. Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum 43 (2000) 1897-1900
30. Higashi N., Mita H., Taniguchi M., Turikisawa N., Higashi A., Ozawa Y., et al. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J Allergy Clin Immunol 114 (2004) 1353-1358
31. Slot M.C., Links T.P., Stegeman C.A., and Tervaert J.W. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. Arthritis Rheum 53 (2005) 108-113
32. Fujieda M., Suzuki K., Sato H., Hattori M., Wada N., Tsuchiya M., et al. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil. Clin Nephrol 63 (2005) 437-445
33. von Schmiedeberg S., Hanten U., Goebel C., Schuppe H.C., Uetrecht J., and Gleichmann E. T cells ignore the parent drug propylthiouracil but are sensitized to a reactive metabolite generated in vivo. Clin Immunol Immunopathol 80 (1996) 162-170
34. Harper L., Chin L., Daykin J., Allahabadia A., Heward J., Gough S.C., et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf) 60 (2004) 671-675